SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-145027
Filing Date
2023-05-15
Accepted
2023-05-15 16:17:32
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d87653d10q.htm   iXBRL 10-Q 1147593
2 EX-10.1 d87653dex101.htm EX-10.1 22334
3 EX-31.1 d87653dex311.htm EX-31.1 6843
4 EX-31.2 d87653dex312.htm EX-31.2 6242
5 EX-32.1 d87653dex321.htm EX-32.1 6701
  Complete submission text file 0001193125-23-145027.txt   5382058

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20230331.xsd EX-101.SCH 47717
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20230331_cal.xml EX-101.CAL 32886
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20230331_def.xml EX-101.DEF 182664
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20230331_lab.xml EX-101.LAB 379199
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20230331_pre.xml EX-101.PRE 306357
63 EXTRACTED XBRL INSTANCE DOCUMENT d87653d10q_htm.xml XML 677380
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 23922691
SIC: 2834 Pharmaceutical Preparations